Ethyl 4-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate, 95.0%, 1g

4-{[1,1'-biphenyl]-4-carbonyl}-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

Ethyl 6-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate, 98+%, 1g

2,5,8,11-Tetraoxatridecan-13-ol, 95.0%, 100g

TERT-BUTYL (5-BROMOQUINOLIN-2-YL)CARBAMATE, 95.0%, 250mg

trans,trans-4-Methoxy-4'-propyl-1,1'-bicyclohexyl>98.0%(GC)5g

5-Bromo-4-chloro-6-phenylfuro[2,3-d]pyrimidine, 97%, 100mg

6,7-Dihydro-4H-pyrazolo[5,1-c][1,4]oxazine-2-carbaldehyde, 98%, 250mg

D-valina, mín. 98,5 %, para bioquímica, 25 g, envase de plástico.

(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol, 97.0%, 10g

Methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate hydrochloride, 98%, 250mg

Solución estándar multielemento ICP XVII, ROTI®Star, 100 ml, HDPE

D-(+)-Glucose>98.0%(GC)500g